Table 2.
Results of the univariate analysis with respect to overall survival (OS) and time to progression (TTP).
| OS | TTP | |||
|---|---|---|---|---|
| VARIABLE | exp(coef)ŧ | P value | exp(coef)ŧ | P value |
| Age | 1.1113 | 0.142 | 1.0159 | 0.833 |
| Gender | 0.8126 | 0.516 | 1.3302 | 0.420 |
| Weight | 1.0098 | 0.413 | 1.0007 | 0.956 |
| Clinical signs | 1.9885 | 0.036* | 1.7104 | 0.106 |
| Hypercalcemia | 1.8522 | 0.149 | 1.4900 | 0.342 |
| Metastasis (Lymph node) | 3.0245 | 0.001* | 3.8686 | <0.001* |
| Side | 1.2767 | 0.594 | 1.5037 | 0.453 |
| Size | 1.2984 | <0.001* | 1.2378 | 0.007* |
| Lymph node extirpation | 3.0245 | 0.001* | 3.8686 | <0.001* |
| Complications | 3.4844 | <0.001* | 11.5647 | <0.001* |
| Chemotherapy | 0.7415 | 0.324 | 1.0163 | 0.960 |
| Start days | 1.0027 | 0.933 | 1.0368 | 0.251 |
| No of treatments | 0.6078 | 0.193 | 0.9033 | 0.783 |
| Toxicity | 0.7175 | 0.485 | 0.7421 | 0.501 |
| Dose Reductions | 0.6356 | 0.416 | 0.6615 | 0.448 |
| Progression | 2.8555 | 0.004* | NA | NA |
| Local progression | 0.4651 | 0.047* | 0.4782 | 0.034* |
| Lymph node progression | 1.1806 | 0.690 | 1.2625 | 0.520 |
| Pulmonary progression | 1.3102 | 0.539 | 1.7632 | 0.187 |
| Progression elsewhere | 2.1453 | 0.306 | 1.5109 | 0.579 |
| Treatment for progression | 0.4043 | 0.020* | 1.1461 | 0.697 |
ŧ
Exponential (coefficient) is defined as the multiplied relative risk of an event (death or progression) occurring for a unit change in the variable.
*
Statistically significant P= <0.05